20976576

Source:http://linkedlifedata.com/resource/pubmed/id/20976576

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001565, umls-concept:C0021083, umls-concept:C0041703, umls-concept:C0087111, umls-concept:C0205540
pubmed:issue	1
pubmed:dateCreated	2011-1-13
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101096440
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1534-6315
pubmed:author	pubmed-author:CanonicaWalterW, pubmed-author:CompalatiEnricoE, pubmed-author:CoxLindaL
pubmed:issnType	Electronic
pubmed:volume	11
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	4-6
pubmed:meshHeading	pubmed-meshheading:20976576-Administration, Sublingual, pubmed-meshheading:20976576-Desensitization, Immunologic, pubmed-meshheading:20976576-Drug Approval, pubmed-meshheading:20976576-Humans, pubmed-meshheading:20976576-Physician's Practice Patterns, pubmed-meshheading:20976576-United States, pubmed-meshheading:20976576-United States Food and Drug Administration
pubmed:year	2011
pubmed:articleTitle	Will sublingual immunotherapy become an approved treatment method in the United States?
pubmed:affiliation	Nova Southeastern University, 5333 North Dixie Highway, Fort Lauderdale, FL 33334, USA. lindaswolfcox@msn.com
pubmed:publicationType	Journal Article